Hospira believes that it can increase its supply to the market if it can secure additional methotrexate active ingredient supply.
Hospira increased production of the drug to make up for the supply gap that occurred when another supplier faced production challenges in the second half of 2011, the company said.
Hospira supports President Obama’s order to broaden reporting of potential shortages, Pharmaceutical Online reports.